These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 31219890)

  • 21. Availability of HIV prevention and treatment services for people who inject drugs: findings from 21 countries.
    Petersen Z; Myers B; van Hout MC; Plüddemann A; Parry C
    Harm Reduct J; 2013 Aug; 10():13. PubMed ID: 23957896
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment advocate tactics to expand access to antiviral therapy for HIV and viral hepatitis C in low- to high-income settings: making sure no one is left behind.
    Grillon C; Krishtel PR; Mellouk O; Basenko A; Freeman J; Mendão L; Andrieux-Meyer I; Morin S
    J Int AIDS Soc; 2018 Apr; 21 Suppl 2(Suppl Suppl 2):e25060. PubMed ID: 29633580
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Population estimation and harm reduction among people who inject drugs in Addis Ababa, Ethiopia.
    Deyessa N; Senbete B; Abdo A; Mundia BM
    Harm Reduct J; 2020 Sep; 17(1):61. PubMed ID: 32894153
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Global Fund investments in harm reduction from 2002 to 2009.
    Bridge J; Hunter BM; Atun R; Lazarus JV
    Int J Drug Policy; 2012 Jul; 23(4):279-85. PubMed ID: 22421551
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Developing integrated community-based HIV prevention, harm reduction, and sexual and reproductive health services for women who inject drugs.
    Ayon S; Jeneby F; Hamid F; Badhrus A; Abdulrahman T; Mburu G
    Reprod Health; 2019 May; 16(Suppl 1):59. PubMed ID: 31138238
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Women and barriers to harm reduction services: a literature review and initial findings from a qualitative study in Barcelona, Spain.
    Shirley-Beavan S; Roig A; Burke-Shyne N; Daniels C; Csak R
    Harm Reduct J; 2020 Oct; 17(1):78. PubMed ID: 33076931
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HaRePo (harm reduction by post): an innovative and effective harm reduction programme for people who use drugs using email, telephone, and post service.
    Torres-Leguizamon M; Reynaud EG; Néfau T; Duplessy C
    Harm Reduct J; 2020 Aug; 17(1):59. PubMed ID: 32831094
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Drug consumption rooms in Catalonia: A comprehensive evaluation of social, health and harm reduction benefits.
    Folch C; Lorente N; Majó X; Parés-Badell O; Roca X; Brugal T; Roux P; Carrieri P; Colom J; Casabona J;
    Int J Drug Policy; 2018 Dec; 62():24-29. PubMed ID: 30352331
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Social network support and harm reduction activities in a peer researcher-led pilot study, British Columbia, Canada.
    Elkhalifa S; Jozaghi E; Marsh S; Thomson E; Gregg D; Buxton J; Jolly A
    Harm Reduct J; 2020 Aug; 17(1):57. PubMed ID: 32825836
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The cost-effectiveness of harm reduction.
    Wilson DP; Donald B; Shattock AJ; Wilson D; Fraser-Hurt N
    Int J Drug Policy; 2015 Feb; 26 Suppl 1():S5-11. PubMed ID: 25727260
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The development of peer educator-based harm reduction programmes in Northern Vietnam.
    Walsh N; Gibbie TM; Higgs P
    Drug Alcohol Rev; 2008 Mar; 27(2):200-3. PubMed ID: 18264883
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 'It's too much, I'm getting really tired of it': Overdose response and structural vulnerabilities among harm reduction workers in community settings.
    Kolla G; Strike C
    Int J Drug Policy; 2019 Dec; 74():127-135. PubMed ID: 31590088
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of community-based nurses in harm reduction for HIV prevention: a South East and South Asia case study.
    Limbu B
    Int J Drug Policy; 2008 Jun; 19(3):211-3. PubMed ID: 18440796
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hoots and harm reduction: a qualitative study identifying gaps in overdose prevention among women who smoke drugs.
    Bardwell G; Austin T; Maher L; Boyd J
    Harm Reduct J; 2021 Mar; 18(1):29. PubMed ID: 33678163
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HIV, Drug Injection, and Harm Reduction Trends in Eastern Europe and Central Asia: Implications for International and Domestic Policy.
    LaMonaca K; Dumchev K; Dvoriak S; Azbel L; Morozova O; Altice FL
    Curr Psychiatry Rep; 2019 Jun; 21(7):47. PubMed ID: 31161306
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluating Montréal's harm reduction interventions for people who inject drugs: protocol for observational study and cost-effectiveness analysis.
    Panagiotoglou D; Abrahamowicz M; Buckeridge DL; Caro JJ; Latimer E; Maheu-Giroux M; Strumpf EC
    BMJ Open; 2021 Oct; 11(10):e053191. PubMed ID: 34702731
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Convenience and comfort: reasons reported for using drugs alone among clients of harm reduction sites in British Columbia, Canada.
    Papamihali K; Yoon M; Graham B; Karamouzian M; Slaunwhite AK; Tsang V; Young S; Buxton JA
    Harm Reduct J; 2020 Nov; 17(1):90. PubMed ID: 33228676
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Scaling up HIV prevention efforts targeting people who inject drugs in Central Asia: a review of key challenges and ways forward.
    Boltaev AA; El-Bassel N; Deryabina AP; Terlikbaeva A; Gilbert L; Hunt T; Primbetova S; Strathdee SA
    Drug Alcohol Depend; 2013 Nov; 132 Suppl 1():S41-7. PubMed ID: 24103128
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Harm reduction for young people who use prescription opioids extra-medically: Obstacles and opportunities.
    Marshall BD; Green TC; Yedinak JL; Hadland SE
    Int J Drug Policy; 2016 May; 31():25-31. PubMed ID: 26919826
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.